2013.07.15 Weekly Broadcast Email
There following updates were made to the CCCWF CCOP Research Base website for the week of July 15, 2013.
(Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A Pilot Study)
Please be aware if a patient is enrolled in protocol 99211 the following requirements for SAE’s are defined in Section 10.2 of the protocol. Grades 3, 4 and 5 SAE’s meeting the criteria for a Medwatch need to be reported in both the Quitline Intervention Group and the Usual Care Group. If you have patients in which a Medwatch needs to be submitted, please do so as soon as possible.
13th Annual Meeting Registration:
The CCCWF CCOP Research Base 13th Annual Meeting will be held October 24-26 in Asheville, NC. Please visit our annual meeting website for the meeting agenda, accommodation information, and registration. We look forward to seeing you in October!
(A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy)
The 2013 Continuing Review WF Approval Letter has been posted to the website.